StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.45−0.05 (-3.33%)

Close on Nov 18, 2026Market cap $21.92MP/E –Yield –

CervoMed operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

CervoMed's operating income for the twelve months ending Jun 30, 2026 was -$31.16M. For fiscal 2025 it was -$28.29M. The highest annual figure on record is -$3.48M in fiscal 2022.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$28.29M–
FY2024Dec 31, 2024-$18.23M–
FY2023Dec 31, 2023-$7.81M–
FY2022Dec 31, 2022-$3.48M–
FY2021Dec 31, 2021-$24.68M–
FY2020Dec 31, 2020-$15.97M–
FY2019Dec 31, 2019-$11.55M–
FY2018Dec 31, 2018-$18.96M–
FY2017Dec 31, 2017-$11.35M–
FY2016Dec 31, 2016-$18.37M–
FY2015Dec 31, 2015-$6.41M–
FY2014Dec 31, 2014-$14.61M–
FY2013Dec 31, 2013-$12.80M–
FY2012Dec 31, 2012-$11.79M–
FY2011Dec 31, 2011-$16.43M–
FY2010Dec 31, 2010-$7.64M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.68M–
Q1 FY2026Mar 31, 2026-$8.11M–
Q4 FY2025Dec 31, 2025-$8.33M–
Q3 FY2025Sep 30, 2025-$8.04M–
Q2 FY2025Jun 30, 2025-$6.62M–
Q1 FY2025Mar 31, 2025-$5.30M–
Q4 FY2024Dec 31, 2024-$7.24M–
Q3 FY2024Sep 30, 2024-$5.40M–
Q2 FY2024Jun 30, 2024-$3.00M–
Q1 FY2024Mar 31, 2024-$2.59M–
Q4 FY2023Dec 31, 2023-$2.48M–
Q3 FY2023Sep 30, 2023-$2.68M–
Q2 FY2023Jun 30, 2023-$1.23M–
Q1 FY2023Mar 31, 2023-$1.43M–
Q4 FY2022Dec 31, 2022-$938.82K–
Q3 FY2022Sep 30, 2022-$904.05K–
Q2 FY2022Jun 30, 2022-$4.25M–
Q1 FY2022Mar 31, 2022-$4.55M–
Q4 FY2021Dec 31, 2021-$3.47M–
Q3 FY2021Sep 30, 2021-$12.69M–
Q2 FY2021Jun 30, 2021-$3.83M–
Q1 FY2021Mar 31, 2021-$4.68M-258.5%
Q4 FY2020Dec 31, 2020-$4.09M–
Q3 FY2020Sep 30, 2020-$5.27M–
Q2 FY2020Jun 30, 2020-$3.66M–
Q1 FY2020Mar 31, 2020$2.96M–
Q4 FY2019Dec 31, 2019-$2.96M–
Q3 FY2019Sep 30, 2019-$3.05M–
Q2 FY2019Jun 30, 2019-$2.62M–
Q1 FY2019Mar 31, 2019-$2.92M–
Q4 FY2018Dec 31, 2018-$5.56M–
Q3 FY2018Sep 30, 2018-$6.97M–
Q2 FY2018Jun 30, 2018-$3.08M–
Q1 FY2018Mar 31, 2018-$3.35M–
Q4 FY2017Dec 31, 2017-$2.45M–
Q3 FY2017Sep 30, 2017-$3.35M–
Q2 FY2017Jun 30, 2017-$2.98M–
Q1 FY2017Mar 31, 2017-$2.57M–
Q4 FY2016Dec 31, 2016-$2.54M–
Q3 FY2016Sep 30, 2016-$5.80M–

More CervoMed figures

See a number that looks wrong?